EMD Serono
Dr. Wei Gao is the global head of pharmacometrics and portfolio section head in Quantitative Pharmacology at EMD Serono. In this role, she leads a team responsible for driving the Pharmacometrics strategy and developing cutting-edge modeling and simulation capabilities across various therapeutic areas to enable MIDD throughout the drug development lifecycle. Her group is also accountable for clinical pharmacology strategy in immuno-oncology and targeted therapeutics including ADCs and bispecific.
Prior to her tenure at EMD Serono, Wei served as Neuroscience therapeutic area head and Pharmacometrics group director in the department of Quantitative Pharmacology & Pharmacometrics at Merck Research Laboratories. With a deep commitment to enhancing the field of quantitative clinical pharmacology, Dr. Gao has a proven track record of making impactful contributions both individually and collaboratively, with recognition in scientific societies. Dr. Gao holds a PhD from the State University of New York at Buffalo, focusing on disease progression modeling and mechanistic PK/PD modeling of Type 2 Diabetes under the supervision of Dr. William Jusko. Currently, she serves as the treasurer of the International Society of Pharmacometrics.
Disclosure(s): No financial relationships to disclose